之江生物：拟回购不低于6000万元且不超过1.2亿元公司股份

Group 1 - The company, Zhijiang Biology, announced a share repurchase plan with a total funding amount between RMB 60 million and RMB 120 million, aimed at employee stock ownership plans or equity incentives [1][1][1] - The maximum repurchase price is set at RMB 37.99 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's decision [1][1][1] - The repurchase period is within 12 months from the board's approval date [1][1][1] Group 2 - In 2024, Zhijiang Biology's revenue composition is projected to be 98.25% from the in vitro diagnostic industry and 1.75% from other businesses [1][1][1] - As of the report date, the market capitalization of Zhijiang Biology is RMB 4.3 billion [1][1][1]